GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Shuangcheng Pharmaceuticals Co Ltd (SZSE:002693) » Definitions » Cyclically Adjusted FCF per Share

Hainan Shuangcheng Pharmaceuticals Co (SZSE:002693) Cyclically Adjusted FCF per Share : ¥-0.17 (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Hainan Shuangcheng Pharmaceuticals Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Hainan Shuangcheng Pharmaceuticals Co's adjusted free cash flow per share for the three months ended in Mar. 2024 was ¥-0.074. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥-0.17 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -2.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Hainan Shuangcheng Pharmaceuticals Co was -2.00% per year. The lowest was -2.00% per year. And the median was -2.00% per year.

As of today (2024-06-05), Hainan Shuangcheng Pharmaceuticals Co's current stock price is ¥4.72. Hainan Shuangcheng Pharmaceuticals Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ¥-0.17. Hainan Shuangcheng Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF of today is .


Hainan Shuangcheng Pharmaceuticals Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Hainan Shuangcheng Pharmaceuticals Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hainan Shuangcheng Pharmaceuticals Co Cyclically Adjusted FCF per Share Chart

Hainan Shuangcheng Pharmaceuticals Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -0.16 -0.15 -0.17 -0.17

Hainan Shuangcheng Pharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.17 -0.17 -0.18 -0.17 -0.17

Competitive Comparison of Hainan Shuangcheng Pharmaceuticals Co's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Hainan Shuangcheng Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hainan Shuangcheng Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hainan Shuangcheng Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Hainan Shuangcheng Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF falls into.



Hainan Shuangcheng Pharmaceuticals Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hainan Shuangcheng Pharmaceuticals Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.074/115.2271*115.2271
=-0.074

Current CPI (Mar. 2024) = 115.2271.

Hainan Shuangcheng Pharmaceuticals Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.012 98.200 -0.014
201409 -0.018 98.900 -0.021
201412 -0.062 99.000 -0.072
201503 -0.178 99.900 -0.205
201506 -0.155 99.500 -0.179
201509 -0.136 100.500 -0.156
201512 -0.126 100.600 -0.144
201603 -0.215 102.200 -0.242
201606 -0.094 101.400 -0.107
201609 -0.023 102.400 -0.026
201612 -0.038 102.600 -0.043
201703 -0.060 103.200 -0.067
201706 -0.205 103.100 -0.229
201709 0.034 104.100 0.038
201712 0.031 104.500 0.034
201803 0.032 105.300 0.035
201806 -0.022 104.900 -0.024
201809 -0.016 106.600 -0.017
201812 0.071 106.500 0.077
201903 0.036 107.700 0.039
201906 -0.022 107.700 -0.024
201909 -0.003 109.800 -0.003
201912 0.022 111.200 0.023
202003 -0.063 112.300 -0.065
202006 -0.095 110.400 -0.099
202009 -0.015 111.700 -0.015
202012 0.025 111.500 0.026
202103 -0.021 112.662 -0.021
202106 -0.011 111.769 -0.011
202109 0.031 112.215 0.032
202112 -0.010 113.108 -0.010
202203 -0.054 114.335 -0.054
202206 0.010 114.558 0.010
202209 -0.027 115.339 -0.027
202212 0.039 115.116 0.039
202303 -0.062 115.116 -0.062
202306 -0.022 114.558 -0.022
202309 -0.044 115.339 -0.044
202312 0.036 114.781 0.036
202403 -0.074 115.227 -0.074

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Hainan Shuangcheng Pharmaceuticals Co  (SZSE:002693) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Hainan Shuangcheng Pharmaceuticals Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Hainan Shuangcheng Pharmaceuticals Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Hainan Shuangcheng Pharmaceuticals Co (SZSE:002693) Business Description

Traded in Other Exchanges
N/A
Address
16 Xingguo Road, Xiuying District, Haikou, CHN, 570311
Hainan Shuangcheng Pharmaceuticals Co Ltd is engaged in the research, development, and sales of synthesized peptide drugs.
Executives
Yuan Jian Lin Executives
Zhang Wei Executives
Yu Xiao Feng Directors, executives
Wang Xu Guang Executives
Directors, executives
Wang Cheng Dong Directors, executives
Executives
Hu Yi Securities Affairs Representative

Hainan Shuangcheng Pharmaceuticals Co (SZSE:002693) Headlines

No Headlines